Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 207

1.

Individual short-acting opioids and the risk of opioid-related adverse events in adolescents.

Chung CP, Callahan ST, Cooper WO, Dupont WD, Murray KT, Franklin AD, Hall K, Dudley JA, Stein CM, Ray WA.

Pharmacoepidemiol Drug Saf. 2019 Nov;28(11):1448-1456. doi: 10.1002/pds.4872. Epub 2019 Aug 16.

PMID:
31418512
2.

Association of Antipsychotic Treatment With Risk of Unexpected Death Among Children and Youths.

Ray WA, Stein CM, Murray KT, Fuchs DC, Patrick SW, Daugherty J, Hall K, Cooper WO.

JAMA Psychiatry. 2019 Feb 1;76(2):162-171. doi: 10.1001/jamapsychiatry.2018.3421.

PMID:
30540347
3.

Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding.

Ray WA, Chung CP, Murray KT, Smalley WE, Daugherty JR, Dupont WD, Stein CM.

JAMA. 2018 Dec 4;320(21):2221-2230. doi: 10.1001/jama.2018.17242.

PMID:
30512099
4.

Outpatient Opioid Prescriptions for Children and Opioid-Related Adverse Events.

Chung CP, Callahan ST, Cooper WO, Dupont WD, Murray KT, Franklin AD, Hall K, Dudley JA, Stein CM, Ray WA.

Pediatrics. 2018 Aug;142(2). pii: e20172156. doi: 10.1542/peds.2017-2156. Epub 2018 Jul 16.

5.

Comparative out-of-hospital mortality of long-acting opioids prescribed for non-cancer pain: A retrospective cohort study.

Chung CP, Dupont WD, Murray KT, Hall K, Stein CM, Ray WA.

Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):48-53. doi: 10.1002/pds.4619. Epub 2018 Jul 12.

PMID:
30003613
6.

High-Dose Citalopram and Escitalopram and the Risk of Out-of-Hospital Death.

Ray WA, Chung CP, Murray KT, Hall K, Stein CM.

J Clin Psychiatry. 2017 Feb;78(2):190-195. doi: 10.4088/JCP.15m10324.

7.

Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding.

Ray WA, Chung CP, Murray KT, Smalley WE, Daugherty JR, Dupont WD, Stein CM.

Gastroenterology. 2016 Dec;151(6):1105-1112.e10. doi: 10.1053/j.gastro.2016.08.054. Epub 2016 Sep 14.

8.

Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain.

Ray WA, Chung CP, Murray KT, Hall K, Stein CM.

JAMA. 2016 Jun 14;315(22):2415-23. doi: 10.1001/jama.2016.7789.

9.

Development of an algorithm to identify serious opioid toxicity in children.

Chung CP, Callahan ST, Cooper WO, Murray KT, Hall K, Dudley JA, Stein CM, Ray WA.

BMC Res Notes. 2015 Jul 4;8:293. doi: 10.1186/s13104-015-1185-x.

10.

Out-of-hospital mortality among patients receiving methadone for noncancer pain.

Ray WA, Chung CP, Murray KT, Cooper WO, Hall K, Stein CM.

JAMA Intern Med. 2015 Mar;175(3):420-7. doi: 10.1001/jamainternmed.2014.6294.

11.

Genotype and risk of major bleeding during warfarin treatment.

Kawai VK, Cunningham A, Vear SI, Van Driest SL, Oginni A, Xu H, Jiang M, Li C, Denny JC, Shaffer C, Bowton E, Gage BF, Ray WA, Roden DM, Stein CM.

Pharmacogenomics. 2014 Dec;15(16):1973-83. doi: 10.2217/pgs.14.153.

12.

Performance of time-dependent propensity scores: a pharmacoepidemiology case study.

Ray WA, Liu Q, Shepherd BE.

Pharmacoepidemiol Drug Saf. 2015 Jan;24(1):98-106. doi: 10.1002/pds.3727. Epub 2014 Nov 18.

13.

Azithromycin associated with a reduction in 90-day mortality among older pneumonia patients, although a true clinical benefit is uncertain.

Ray WA.

Evid Based Med. 2014 Dec;19(6):226-7. doi: 10.1136/ebmed-2014-110061. Epub 2014 Aug 13. No abstract available.

14.

Brief report: Risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancy.

Cooper WO, Cheetham TC, Li DK, Stein CM, Callahan ST, Morgan TM, Shintani AK, Chen N, Griffin MR, Ray WA.

Arthritis Rheumatol. 2014 Feb;66(2):444-50. doi: 10.1002/art.38262.

15.

Antidepressants and suicide attempts in children.

Cooper WO, Callahan ST, Shintani A, Fuchs DC, Shelton RC, Dudley JA, Graves AJ, Ray WA.

Pediatrics. 2014 Feb;133(2):204-10. doi: 10.1542/peds.2013-0923. Epub 2014 Jan 6.

16.

Antipsychotics and the risk of type 2 diabetes mellitus in children and youth.

Bobo WV, Cooper WO, Stein CM, Olfson M, Graham D, Daugherty J, Fuchs DC, Ray WA.

JAMA Psychiatry. 2013 Oct;70(10):1067-75. doi: 10.1001/jamapsychiatry.2013.2053.

PMID:
23965896
17.

Identifying suicidal behavior among adolescents using administrative claims data.

Callahan ST, Fuchs DC, Shelton RC, Balmer LS, Dudley JA, Gideon PS, Deranieri MM, Stratton SM, Williams CL, Ray WA, Cooper WO.

Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):769-75. doi: 10.1002/pds.3421. Epub 2013 Feb 15.

18.

Propoxyphene and the risk of out-of-hospital death.

Ray WA, Murray KT, Kawai V, Graham DJ, Cooper WO, Hall K, Stein CM.

Pharmacoepidemiol Drug Saf. 2013 Apr;22(4):403-12. doi: 10.1002/pds.3411. Epub 2013 Feb 14.

19.

Validation of a computer case definition for sudden cardiac death in opioid users.

Kawai VK, Murray KT, Stein CM, Cooper WO, Graham DJ, Hall K, Ray WA.

BMC Res Notes. 2012 Aug 31;5:473. doi: 10.1186/1756-0500-5-473.

20.
21.

Adherence to transcranial Doppler screening guidelines among children with sickle cell disease.

Eckrich MJ, Wang WC, Yang E, Arbogast PG, Morrow A, Dudley JA, Ray WA, Cooper WO.

Pediatr Blood Cancer. 2013 Feb;60(2):270-4. doi: 10.1002/pbc.24240. Epub 2012 Jun 28.

PMID:
22744996
22.

Azithromycin and the risk of cardiovascular death.

Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM.

N Engl J Med. 2012 May 17;366(20):1881-90. doi: 10.1056/NEJMoa1003833.

23.

ADHD medications and risk of serious cardiovascular events in young and middle-aged adults.

Habel LA, Cooper WO, Sox CM, Chan KA, Fireman BH, Arbogast PG, Cheetham TC, Quinn VP, Dublin S, Boudreau DM, Andrade SE, Pawloski PA, Raebel MA, Smith DH, Achacoso N, Uratsu C, Go AS, Sidney S, Nguyen-Huynh MN, Ray WA, Selby JV.

JAMA. 2011 Dec 28;306(24):2673-83. doi: 10.1001/jama.2011.1830. Epub 2011 Dec 12.

24.

Positive predictive value of automated database records for diabetic ketoacidosis (DKA) in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid Study.

Bobo WV, Cooper WO, Epstein RA Jr, Arbogast PG, Mounsey J, Ray WA.

BMC Med Res Methodol. 2011 Nov 23;11:157. doi: 10.1186/1471-2288-11-157.

25.

ADHD drugs and serious cardiovascular events in children and young adults.

Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA.

N Engl J Med. 2011 Nov 17;365(20):1896-904. doi: 10.1056/NEJMoa1110212. Epub 2011 Nov 1.

26.

Performance of disease risk scores, propensity scores, and traditional multivariable outcome regression in the presence of multiple confounders.

Arbogast PG, Ray WA.

Am J Epidemiol. 2011 Sep 1;174(5):613-20. doi: 10.1093/aje/kwr143. Epub 2011 Jul 12.

PMID:
21749976
27.

Improving automated database studies.

Ray WA.

Epidemiology. 2011 May;22(3):302-4. doi: 10.1097/EDE.0b013e31820f31e1. Review. No abstract available.

PMID:
21464650
28.

An automated database case definition for serious bleeding related to oral anticoagulant use.

Cunningham A, Stein CM, Chung CP, Daugherty JR, Smalley WE, Ray WA.

Pharmacoepidemiol Drug Saf. 2011 Jun;20(6):560-6. doi: 10.1002/pds.2109. Epub 2011 Mar 8.

29.

Cardiovascular safety of NSAIDs.

Ray WA.

BMJ. 2011 Jan 11;342:c6618. doi: 10.1136/bmj.c6618. No abstract available.

PMID:
21224323
30.

The ethics of placebo in studies with fracture end points in osteoporosis.

Stein CM, Ray WA.

N Engl J Med. 2010 Sep 30;363(14):1367-70; discussion e21. doi: 10.1056/NEJMsb1006120. No abstract available.

PMID:
20879888
31.

Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.

Ray WA, Murray KT, Griffin MR, Chung CP, Smalley WE, Hall K, Daugherty JR, Kaltenbach LA, Stein CM.

Ann Intern Med. 2010 Mar 16;152(6):337-45. doi: 10.7326/0003-4819-152-6-201003160-00003.

32.

Adherence to prophylactic antibiotic guidelines among Medicaid infants with sickle cell disease.

Warren MD, Arbogast PG, Dudley JA, Kaltenbach L, Ray WA, Wang WC, Cooper WO.

Arch Pediatr Adolesc Med. 2010 Mar;164(3):298-9. doi: 10.1001/archpediatrics.2009.286. No abstract available.

33.

Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease.

Ray WA, Varas-Lorenzo C, Chung CP, Castellsague J, Murray KT, Stein CM, Daugherty JR, Arbogast PG, García-Rodríguez LA.

Circ Cardiovasc Qual Outcomes. 2009 May;2(3):155-63. doi: 10.1161/CIRCOUTCOMES.108.805689. Epub 2009 May 5.

PMID:
20031832
34.

A computer case definition for sudden cardiac death.

Chung CP, Murray KT, Stein CM, Hall K, Ray WA.

Pharmacoepidemiol Drug Saf. 2010 Jun;19(6):563-72. doi: 10.1002/pds.1888.

35.

Implementation of a real-time compliance dashboard to help reduce SICU ventilator-associated pneumonia with the ventilator bundle.

Zaydfudim V, Dossett LA, Starmer JM, Arbogast PG, Feurer ID, Ray WA, May AK, Pinson CW.

Arch Surg. 2009 Jul;144(7):656-62. doi: 10.1001/archsurg.2009.117.

PMID:
19620546
36.

Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations.

Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer SM, Gideon PS, Hall KS, Kaltenbach LA, Ray WA.

Paediatr Perinat Epidemiol. 2009 Jan;23(1):18-28. doi: 10.1111/j.1365-3016.2008.00978.x.

37.

Atypical antipsychotic drugs and the risk of sudden cardiac death.

Ray WA, Chung CP, Murray KT, Hall K, Stein CM.

N Engl J Med. 2009 Jan 15;360(3):225-35. doi: 10.1056/NEJMoa0806994. Erratum in: N Engl J Med. 2009 Oct 29;361(18):1814.

38.

Use of disease risk scores in pharmacoepidemiologic studies.

Arbogast PG, Ray WA.

Stat Methods Med Res. 2009 Feb;18(1):67-80. doi: 10.1177/0962280208092347. Epub 2008 Jun 18. Review.

PMID:
18562398
39.

The aprotinin story--is BART the final chapter?

Ray WA, Stein CM.

N Engl J Med. 2008 May 29;358(22):2398-400. doi: 10.1056/NEJMe0803514. Epub 2008 May 14. No abstract available.

PMID:
18480197
40.

Health plan notification and feedback to providers is associated with increased filling of preventer medications for children with asthma enrolled in Medicaid.

Cooper WO, Ray WA, Arbogast PG, Garrison M, Dudley JA, Christakis DA.

J Pediatr. 2008 Apr;152(4):481-8. doi: 10.1016/j.jpeds.2007.08.046. Epub 2007 Nov 5.

PMID:
18346500
41.

Learning from aprotinin--mandatory trials of comparative efficacy and safety needed.

Ray WA.

N Engl J Med. 2008 Feb 21;358(8):840-2. doi: 10.1056/NEJMe0800268. No abstract available.

PMID:
18287607
42.

Increasing exposure to angiotensin-converting enzyme inhibitors in pregnancy.

Bowen ME, Ray WA, Arbogast PG, Ding H, Cooper WO.

Am J Obstet Gynecol. 2008 Mar;198(3):291.e1-5. doi: 10.1016/j.ajog.2007.09.009. Epub 2008 Jan 14.

PMID:
18191803
43.

Adjustment for multiple cardiovascular risk factors using a summary risk score.

Arbogast PG, Kaltenbach L, Ding H, Ray WA.

Epidemiology. 2008 Jan;19(1):30-7.

PMID:
18091000
44.

Positive predictive value of computerized records for major congenital malformations.

Cooper WO, Hernandez-Diaz S, Gideon P, Dyer SM, Hall K, Dudley J, Cevasco M, Thompson AB, Ray WA.

Pharmacoepidemiol Drug Saf. 2008 May;17(5):455-60.

PMID:
18081215
45.

Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?

Austin MT, Poulose BK, Ray WA, Arbogast PG, Feurer ID, Pinson CW.

Arch Surg. 2007 Nov;142(11):1079-85.

PMID:
18025337
46.

Racial differences in antidepressant treatment preceding suicide in a Medicaid population.

Ray WA, Hall K, Meador KG.

Psychiatr Serv. 2007 Oct;58(10):1317-23.

PMID:
17914009
47.

Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.

Ray WA, Chung CP, Stein CM, Smalley WE, Hall K, Arbogast PG, Griffin MR.

Gastroenterology. 2007 Sep;133(3):790-8. Epub 2007 Jul 3.

PMID:
17854591
48.

Effect of regulatory warnings on antidepressant prescribing for children and adolescents.

Kurian BT, Ray WA, Arbogast PG, Fuchs DC, Dudley JA, Cooper WO.

Arch Pediatr Adolesc Med. 2007 Jul;161(7):690-6.

PMID:
17606833
49.

Increasing use of antidepressants in pregnancy.

Cooper WO, Willy ME, Pont SJ, Ray WA.

Am J Obstet Gynecol. 2007 Jun;196(6):544.e1-5.

PMID:
17547888
50.

Major congenital malformations after first-trimester exposure to ACE inhibitors.

Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA.

N Engl J Med. 2006 Jun 8;354(23):2443-51.

Supplemental Content

Support Center